HIPRA Biotech Services is a Contract Development and Manufacturing Organisation (CDMO) that provides cutting-edge biologics services to the pharmaceutical and biotechnology industries.

HIPRA Biotech Services offers comprehensive contract development and manufacturing services across a wide range of biologics technologies. The company delivers a full spectrum of services, from early-stage research and process development to large-scale commercial production, ensuring high-quality standards and agility. Located in Western Europe, HIPRA’s state-of-the-art facilities adhere to EU GMP regulations, advancing strategic autonomy and ensuring global regulatory compliance.

Key Products and Services:

Contract Development: Biologics cell line and strain development, process development, scale-up, and analytical methods development.
Contract Manufacturing: Cell culture platform, microbial platform, aseptic fill-and-finish.
Commercial Manufacturing: Full-scale production with stringent quality management systems.

HIPRA Biotech Services is committed to advancing biologics development and manufacturing, providing innovative solutions and personalised support, accelerating clients’ success in bringing products to market.